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interventions with major psychotic illnesses—especially exploring what
treatments are most effective at each stage of illness and counselor preparation
for complex differential DSM diagnosis.
Authors’ Note: At the time of VISTAS acceptance of this paper, the American Psychiatric
Association (APA) was considering APS (Attenuated Psychosis Syndrome) as a proposed
diagnosis in the psychotic disorders section of the DSM-5. The APA recently made the decision
to not include the new diagnosis with the psychotic disorders and moved it to section III of the
DSM-5 for more research. The authors of this paper are supportive of this decision for reasons
described in the paper. We do however feel that the paper maintains relevance because the of the
current rise of early intervention programs for psychotic disorders across the country and the
ongoing use of the Structured Interview for Psychosis Risk Syndromes (SIPS) tool by counselors
to identify individuals who may be at risk of psychotic disorders.

Revisions are underway to release the fifth edition of the Diagnostic and
Statistical Manual of Mental Disorder, DSM-5, (American Psychiatric Association, 2012)
One diagnosis that is being considered under the category of Schizophrenia Spectrum and
other Psychotic disorders is Attenuated Psychosis Syndrome (APS). APS is considered a
risk factor for major psychotic disorders such as schizophrenia and bipolar disorder. This
article will focus on the role counselors play in the early diagnosis of at-risk patients and
the importance of an accurate diagnosis. Additionally, the categorization of APS in the
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DSM is considered in an effort to help prevent inappropriate diagnosis and potential
resulting treatment failure. A literature review is presented on the diagnosis of APS by
means of the Structured Interview for Psychosis-Risk Syndrome (SIPS)—currently the
most heavily used assessment tool in the field for identifying those at-risk for
schizophrenia spectrum disorders such as the purposed APS—as well as long term
follow-up of APS patients and their outcomes. Discussion follows on the importance of
counselors becoming well versed on the symptoms of APS to prevent inaccurately
diagnosing this population of patients and potentially causing poor outcomes.
Introduction
Psychosis in general, and schizophrenia specifically, are among the most
debilitating and difficult to treat disorders in mental health (Correll, Hauser, Auther, &
Cornblatt, 2010). Identifying a patient with at-risk symptoms before the first episode of
schizophrenia can be invaluable to the patient, clinician, and the community because the
patient is treated early in the course of the disease where treatment is highly effective.
After years of research it has been confirmed that at-risk symptoms for schizophrenia
generally precede the first episode of psychosis, which results in the diagnosis of
schizophrenia (Correll et al., 2010). At present however, the assessment and recognition
of these symptoms for schizophrenia or APS remain under debate (Carpenter, 2009).
Research has shown that utilizing low dose antipsychotic medication, cognitive
behavioral therapy, and having a supportive family and social environment are essential
resources to recovery and reduction of trauma for a patient experiencing symptoms of
APS (Lencz, Smith, Auther, Correll, & Cornblatt, 2003; McGlashan, Walsh, & Woods,
2010; Olsen & Rosenbaum, 2006; Portland Identification and Early Referral Program,
2009; S.Trevino, personal communication, November 18, 2010). At this time research
shows that early detection of APS symptoms can achieve secondary and tertiary
prevention, such as delaying the onset of psychosis and reducing suicide, but does not
prevent schizophrenia from occurring (McGlashan, et al., 2010.)
There are various ways in which counselors can receive referrals to assess a
patient for APS. The patient can be referred by a family member, a health care provider,
a school administrator, a court order, another clinician, or by the patient directly. A
clinical assessment encounter with the patient is then needed. The encounter should use a
multi-method approach of clinical interviewing and assessment tests to diagnose and help
place the patient in the appropriate treatment algorithm. At first referral to a clinician, the
patient may not present with a need to assess for APS. Recognizing a broad marker for
instability, such as multiple AXIS I diagnoses without clear criteria, may be an effective
first clue that a patient may be exhibiting APS symptoms and warrant a diagnostic
assessment.
One goal of this paper is to describe the current diagnostic tools for APS,
especially the Structured Interview for Psychosis-Risk Syndrome, SIPS, (McGlashan, et
al., 2010). The SIPS assessment tool is a comprehensive assessment tool that can be used
in the field to diagnose early detection for schizophrenia and monitor symptom severity.
Evaluating the inclusion criteria of APS into the DSM-5 under the diagnostic
category of Schizophrenia Spectrum and other Psychotic Disorder is another purpose of
this paper. Based on recent information provided by the American Psychiatric
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Association’s Task Force on DSM-5, dated April 27, 2012, the diagnosis of APS has
been recommended for further research and proposed for Section III of the DSM-5. The
authors agree with the direction that the DSM-5 task force has taken to require further
research in this important diagnosis. Creating a diagnosis that treats prodromal psychosis
as a precursor to schizophrenia and not a precursor for other well recognized disorders
with psychotic features such as bipolar, trauma, and stressor-related disorders is a
disservice and dangerous to the patient.
Literature Review
The SIPS is to be administered by trained clinicians of many mental health
disciplines including clinicians and clinical researchers possessing at least a bachelor’s
degree (McGlashan et al., 2010). Tables 1-3, created by the present authors, summarizes
what the SIPS assessment tool aims to achieve in assessing for and diagnosing APS based
on The Psychosis-Risk Syndrome: Handbook for diagnosis and follow up (McGlashan et
al., 2010). The SIPS is a semi-structured interview that is given by a clinician to a patient
and their family members. The assessment process may take from 1 to 3 hours.
Clinicians administer the SIPS in three stages. The first section is the Presence of
Psychotic Symptoms criteria (POPS) and is administered to rule out current or past
psychosis in a patient. The second stage of the SIPS is the Criteria of Psychosis Risk
Syndrome (COPS). It aims to identify if the patient exhibits one or more symptoms of
the three types of Psychosis Risk Syndrome (PRS): Brief Intermittent Psychotic
Syndrome, Attenuated Positive Symptom Syndrome (which is most similar to the criteria
for the proposed DSM-5 APS diagnosis), and Genetic Risk and Deterioration Syndrome.
The third section, the Scale of Psychosis Risk Syndrome (SOPS), assesses the rate and
severity of the PRS. The SOPS scale is listed first, in Table 1, which is out of sequence
with the administering stages because the SOPS scale is used to evaluate the POPS and
COPS.
The reliability and predictive validity of the SIPS tools has been researched
(Correll et al., 2010; Lencz et al., 2003; McGlashan et al., 2010; Miller et al., 2003; Olsen
& Rosenbaum, 2006). In a reliability study done by Miller et al. in 2002, raters
administering the SIPS were 93% consistent in their assessment of whether subjects were
at a baseline prodromal or non-prodromal state. The study listed the validity of the SIPS
tools to predict patients developing a first episode of schizophrenia after baseline
assessment of psychosis risk syndromes including APS. Predicting the onset of
schizophrenic psychosis within 6 months after baseline the SIPS had an accuracy of 46%
and 54% at 12 months.
Discussion
Accurate and early diagnosis of APS is critical to treating the patient
appropriately and in obtaining the best therapeutic results. Currently a broad diagnosis of
psychotic disorder not otherwise specified in the DSM-IV-TR is most often used when
treating this APS population (American Psychiatric Association, 2000). However a
psychotic disorder not otherwise specified diagnosis may not be specific enough to make
treatment recommendations. Early recognition research has shown that patients
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designated as at risk for psychosis can develop a range of diagnoses such as
schizophrenia, bipolar disorder, post traumatic stress disorder, substance induced
psychosis, or have no diagnosis (Rossler et al., 2001). Each of these diagnoses carries a
different treatment protocol. If a new category is to be created in the DSM-5 for
Attenuated Psychosis Syndrome (McGlashan, et al., 2010), attention should be drawn to
broadening the differential diagnosis assessment to prevent over or inaccurately
diagnosing patients with APS and then subsequently inaccurately diagnosing those
patients with a major psychosis syndrome. This is especially true with the ultimate
diagnosis of schizophrenia in a patient who may have another cause of psychosis such as
bipolar disorder.
A strong therapeutic alliance between the patient and clinician is also important to
correctly assess for APS symptoms (McGlashan et al., 2010; Wong et al., 2009) and
result in the potential for a more accurate diagnosis. If a patient does not feel safe in
sharing their experiences with the clinician during evaluation, the results will not be
accurate. A clinician’s role is to help the patient in the reduction of trauma; therefore the
clinician must use any assessment tool with sensitivity and patient focused actions in
developing a therapeutic alliance.
There are over six assessment tools existing today that clinicians can use to
identify APS symptoms (Olsen & Rosenbaum, 2006). The two most heavily used in the
field are the Comprehensive Assessment of At-Risk Mental States (CAARMS) and the
Structured Interview for Psychosis-Risk Syndrome (SIPS). The authors of The PsychosisRisk Syndrome Handbook for Diagnosis and Follow-up and the developers of the SIPS
tool explain the differences between these two assessment tools:
CAARMS was originally crafted to be a diagnostic instrument. The SIPS
on the other hand was designed to diagnose not only the risk syndromes
but also the presence of or conversion to psychosis, and to rate the severity
of risk symptoms longitudinally, i.e., to measure change with time and
treatments. (McGlashan et al., 2010, p. 16)
The SIPS provides a clinician the ability to assess for APS symptoms as well as to
rate the severity of the symptoms. The formal and lengthy process of administering the
SIPS could be a challenge to the development of the therapeutic alliance.
Early intervention has shown to be invaluable in alleviating and reducing trauma
experienced by a patient with APS symptoms. However, various tools can only be
effective to use in assessing APS symptoms if a patient is open and honest in their
responses during an evaluation by a clinician and a therapeutic alliance has been
established prior to the assessment. This may be easier to establish with APS patients
versus those with fully developed schizophrenia, as insight into their symptoms remains
preserved.
Family members and friends that have a relationship with a patient experiencing
APS symptoms can be resources to referring a patient to a clinician. However, in some
cases family members do not recognize their loved ones are experiencing APS symptoms
(Ruston, 2010; Smiley, Plotch, Oppenheim, & Vine Street Pictures, 2006). In order for
clinicians to recognize and assess a patient for APS it is necessary that the patient be
evaluated with valid and reliable tools such as the SIPS.
Sometimes fear and stigma exist that prevent a patient from being evaluated or
sharing their psychosis experience with others (Smiley et al., 2006; Wong et al., 2009). It
4
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takes insight, education, and awareness of changes in the behavior in a patient that can
warrant an evaluation by a clinician. Stigma and the negative effects on families and
patients and the effect on early detection or assessment is challenging for clinicians
because the clinicians are often not trained to recognize psychosis until it meets DSM
criteria for schizophrenia. Therefore, accurate and early diagnosis of APS is important in
placing the patient into the most effective treatment protocol whether it is schizophrenia
or another cause of psychosis. An effective treatment strategy based upon an accurate
diagnosis is critical for the best outcome.
Despite the advantages of early recognition, there are also risks that all mental
health clinicians, including professional counselors, should be aware of when working
with this population. A diagnosis of APS, accurate or not, may result in a referral to a
physician whom may prescribe high dose medications. The popular wisdom that high
dose antipsychotic medications are the obvious choice for people experiencing APS
symptoms, based on their effectiveness with those patients who met full diagnostic
criteria for schizophrenia, may have iatrogenic consequences. Alternative psychosocial
counseling interventions may be more appropriate for patients with APS symptoms
(Kane, Krystal, & Correll, 2003). Bentall and Morrison (2002) suggested that the use of
antipsychotic medications at all might be dangerous because of the aversive side effects.
Further, their effect on the developing brain of adolescents, the age in which APS criteria
is most likely to be met, is yet unknown (Bola, Kao, & Soydan, 2011).
Counselors may offer strength in the areas of accurate empathy and rapport
building for patients with APS symptoms. Diagnostic training is crucial for APS and is
limited at this time (Council for Accreditation of Counseling & Related Educational
Programs, 2011). It is essential for counselors to receive postgraduate training on early
recognition tools such as the SIPS to aid in proper diagnosis, and ultimately treatment,
which maximizes benefits and minimizes risks for the patient.
Any assessment tool could be ineffective, regardless of training if a patient is not
willing to seek professional attention. As a greater goal, our culture might work toward
minimizing any existing negative stigmas regarding schizophrenia and toward
encouraging accurate early recognition of symptoms. There is a sense of great optimism
and hope in the research being done today on APS, that this greater goal may be reached;
hence, the consideration for this diagnosis as a new category in the DSM-5. The hope is
the final decision on inclusion of APS has the desired effect of early recognition and
more appropriate treatment as opposed to misdiagnosis and further perpetuation of an
already poorly understand condition. Properly trained and sensitive counselors may be
helpful in achieving this goal.
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Table 1.
Scale of Psychosis Risk Syndrome (SOPS)
Sections of the SOPS
Positive symptoms

Negative symptoms

Disorganization
symptoms

General symptoms

Subsections
1. Unusual thought content/
Delusional Ideas
2. Suspiciousness/Persecutory
Ideas
3. Grandiose Ideas
4. Perceptual
Abnormalities/Hallucinations
5. Disorganized Communication
1. Social Anhedonia
2. Avolition
3. Expression of Emotions and
Self
4. Experience of Emotions and
Self
5. Ideational Richness
6. Occupational Functioning
1. Odd Behavior of Appearance
2. Bizarre Thinking
3. Trouble with Focus and
Attention
4. Impairment in Personal
Hygiene
1. Sleep Disturbance
2. Dysphoric Mood
3. Motor Disturbances
4. Impaired Tolerance to Normal
Stress

Measures
Several interview questions
are asked by the clinician to
the patient requiring a “N” or
no, “NI”=no information, or
“Y” yes response.
If a “Y” response is given for a
question additional questions
are asked to obtain more
information.
Two types of severity scales:
1. For positive symptoms
ranging from 0
(absent) to 6 (severe
and psychotic)
2. For negative,
disorganized and
general symptoms
ranging from 0
(absent) to 6
(Extreme)

8

Summary
The total combined SOPS score for the four
sections do not affect the diagnosis of PRS
but are taken to quantify the range and
severity of the PRS symptoms. The SOPS
scales are used in the COPS and POPS
sections of the SIPS.
Number of questions requiring a “Y,N,NI”
response per section:
Positive Symptoms: 48
Negative Symptoms: 13
Disorganization Symptoms: 9
General Symptoms: 4
Number of Severity Scale questions
administered per section:
Positive Symptoms: 5
Negative Symptoms: 6
Disorganization Symptoms: 4
General Symptoms: 4
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Table 2.
Presence of Psychotic Symptoms Criteria (POPS)
Assessment types

Measures

Summary

Initial screening (pre-POPS)

Intuitive freedom given to a trained clinician to assess for
psychosis in the past or present. Questions would
include but are not limited to history of trauma, abuse,
learning disability, developmental history, substance
abuse, recent changes, family history of psychosis, and
any extraordinary life circumstances.
Positive Symptoms scale for 1. The patient scores “6” on any one of the SOPS
SOPS and
positive symptoms questions.
Frequency/Duration/Urgency 2. At least one symptom above has occurred for over
one month at a minimum frequency of four days per
week and one hour of those days.
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Clinicians can rule out current and past
episodes of psychosis and should not
use the SIPS if a patient meets these
criteria.
A positive assessment for a current or
past psychosis requires both measures
to be met.
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Table 3.
Criteria of Psychosis-Risk Syndrome (COPS)
Types of PRS
Brief Intermittent
Psychotic Syndrome
(BIPS): Psychotic
symptoms that are very
brief and recent.

Attenuated Positive
Symptom Syndrome
(APSS): Positive
attenuated psychosis-risk
level symptoms that are
severe and frequent.

Genetic Risk and
Deterioration Syndrome
(GRDS): Combined
genetic risk for a
schizophrenic disorder
and a recent
deterioration of
functionality.

Length or frequency of
symptoms
Began in the past three
months, is present
several minutes in one
day with a frequency of
at least once per month.

Measures

Summary

1. The patient scores “6” on any one of the
SOPS Positive Symptoms section questions.
2. If any of the “6” scores have occurred in
the last three months.
3. If both of the above have occurred for at
least several minutes in one day at least
once this month.
4. Lastly that the patient does not better fit into
any other AXIS I or II DSM IV diagnosis.
Began in the past year
1. The patient scores “3-5” on any one of the
or rates on a scale of
SOPS positive symptoms questions.
severity that is one
2. If any of the “3-5” scores begun within the
level higher than 12
past year or currently rate one point higher
months ago, frequency
than last year.
of at least once per
3. If both of the above have occurred at least
week in the past month
once per week in the past month.
at the current level of
4. The patient does not better fit into a DSMintensity.
IV AXIS I or II disorder.
Functional deterioration 1. First-degree relative has had a psychotic
in the last month.
disorder or the patient meets criteria for
Schizotypal Personality disorder based on
the DSM-IV.
2. A current 30% drop in GAF, taken from the
DSM-IV, scores relative to the highest GAF
in the last 12 months.
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The patient would be diagnosed
with BIPS if they met the four
condition measures.

A diagnosis of APSS would be
given if the patient meets the
four criteria measures.

A positive diagnosis for GRDS
would be given if both
measures are met.

